Pretreatment with serine protease inhibitors impairs Leishmania amazonensis survival on macrophages

Abstract Background Leishmaniases are neglected tropical diseases with great clinical and epidemiological importance. The current chemotherapy available for the treatment of leishmaniasis presents several problems, such as adverse effects, toxicity, long treatment time, and parasite resistance. The...

Full description

Saved in:
Bibliographic Details
Main Authors: Patrícia de Almeida Machado, Pollyanna Stephanie Gomes, Elaine Soares Coimbra, Herbert Leonel de Matos Guedes
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Parasites & Vectors
Subjects:
Online Access:https://doi.org/10.1186/s13071-024-06630-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832586020938317824
author Patrícia de Almeida Machado
Pollyanna Stephanie Gomes
Elaine Soares Coimbra
Herbert Leonel de Matos Guedes
author_facet Patrícia de Almeida Machado
Pollyanna Stephanie Gomes
Elaine Soares Coimbra
Herbert Leonel de Matos Guedes
author_sort Patrícia de Almeida Machado
collection DOAJ
description Abstract Background Leishmaniases are neglected tropical diseases with great clinical and epidemiological importance. The current chemotherapy available for the treatment of leishmaniasis presents several problems, such as adverse effects, toxicity, long treatment time, and parasite resistance. The discovery of new therapeutic alternatives is extremely essential, and the discovery of cellular targets is a tool that helps in the development of new drugs. Serine proteases emerge as important virulence factors in the Leishmania genus, as they participate in important processes involved in their infectivity, virulence, and survival. In this work, we evaluated the leishmanicidal effect of different serine protease inhibitors (Benzamidine, PF-429242, PMSF, TLCK, and TPCK). Additionally, we determined the implication of pretreatment with these inhibitors on the entry and survival of parasites within macrophages, as well as the conversion of promastigotes into amastigotes, to discover the importance of serine proteases in the establishment of infection and, consequently, as targets for new drugs for Leishmania. Results In general, the inhibitors had low toxicity in host macrophages, and three showed some effect in promastigote and amastigote forms of L. amazonensis (PF-429242, TLCK, and TPCK). Using a short incubation interval, we pretreated L. amazonensis promastigotes with these five compounds before in vitro infection. Pretreatment with PF-429242, TLCK, and TPCK considerably compromised the survival of these parasites inside host macrophages, without altering the entry of promastigotes into these cells and differentiation into amastigotes. In addition, treatment with PF-429242 and TPCK was able to reduce the serine proteases’ enzymatic activity using subtilisin substrate on L. amazonensis promastigote lysate. Conclusions This work highlights the importance of serine proteases in L. amazonensis as a possible target for new therapeutic alternatives in Leishmania spp. Graphical Abstract
format Article
id doaj-art-da26932b326242d2884306a92edbe66a
institution Kabale University
issn 1756-3305
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Parasites & Vectors
spelling doaj-art-da26932b326242d2884306a92edbe66a2025-01-26T12:17:38ZengBMCParasites & Vectors1756-33052025-01-0118111110.1186/s13071-024-06630-wPretreatment with serine protease inhibitors impairs Leishmania amazonensis survival on macrophagesPatrícia de Almeida Machado0Pollyanna Stephanie Gomes1Elaine Soares Coimbra2Herbert Leonel de Matos Guedes3Laboratório de Imunologia Clínica, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz-FiocruzLaboratório de Imunologia Clínica, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz-FiocruzNúcleo de Pesquisas Em Parasitologia (NUPEP), Instituto de Ciências Biológicas, Universidade Federal de Juiz de ForaLaboratório de Imunologia Clínica, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz-FiocruzAbstract Background Leishmaniases are neglected tropical diseases with great clinical and epidemiological importance. The current chemotherapy available for the treatment of leishmaniasis presents several problems, such as adverse effects, toxicity, long treatment time, and parasite resistance. The discovery of new therapeutic alternatives is extremely essential, and the discovery of cellular targets is a tool that helps in the development of new drugs. Serine proteases emerge as important virulence factors in the Leishmania genus, as they participate in important processes involved in their infectivity, virulence, and survival. In this work, we evaluated the leishmanicidal effect of different serine protease inhibitors (Benzamidine, PF-429242, PMSF, TLCK, and TPCK). Additionally, we determined the implication of pretreatment with these inhibitors on the entry and survival of parasites within macrophages, as well as the conversion of promastigotes into amastigotes, to discover the importance of serine proteases in the establishment of infection and, consequently, as targets for new drugs for Leishmania. Results In general, the inhibitors had low toxicity in host macrophages, and three showed some effect in promastigote and amastigote forms of L. amazonensis (PF-429242, TLCK, and TPCK). Using a short incubation interval, we pretreated L. amazonensis promastigotes with these five compounds before in vitro infection. Pretreatment with PF-429242, TLCK, and TPCK considerably compromised the survival of these parasites inside host macrophages, without altering the entry of promastigotes into these cells and differentiation into amastigotes. In addition, treatment with PF-429242 and TPCK was able to reduce the serine proteases’ enzymatic activity using subtilisin substrate on L. amazonensis promastigote lysate. Conclusions This work highlights the importance of serine proteases in L. amazonensis as a possible target for new therapeutic alternatives in Leishmania spp. Graphical Abstracthttps://doi.org/10.1186/s13071-024-06630-wSerine proteasesSerine proteases inhibitorsLeishmania amazonensis
spellingShingle Patrícia de Almeida Machado
Pollyanna Stephanie Gomes
Elaine Soares Coimbra
Herbert Leonel de Matos Guedes
Pretreatment with serine protease inhibitors impairs Leishmania amazonensis survival on macrophages
Parasites & Vectors
Serine proteases
Serine proteases inhibitors
Leishmania amazonensis
title Pretreatment with serine protease inhibitors impairs Leishmania amazonensis survival on macrophages
title_full Pretreatment with serine protease inhibitors impairs Leishmania amazonensis survival on macrophages
title_fullStr Pretreatment with serine protease inhibitors impairs Leishmania amazonensis survival on macrophages
title_full_unstemmed Pretreatment with serine protease inhibitors impairs Leishmania amazonensis survival on macrophages
title_short Pretreatment with serine protease inhibitors impairs Leishmania amazonensis survival on macrophages
title_sort pretreatment with serine protease inhibitors impairs leishmania amazonensis survival on macrophages
topic Serine proteases
Serine proteases inhibitors
Leishmania amazonensis
url https://doi.org/10.1186/s13071-024-06630-w
work_keys_str_mv AT patriciadealmeidamachado pretreatmentwithserineproteaseinhibitorsimpairsleishmaniaamazonensissurvivalonmacrophages
AT pollyannastephaniegomes pretreatmentwithserineproteaseinhibitorsimpairsleishmaniaamazonensissurvivalonmacrophages
AT elainesoarescoimbra pretreatmentwithserineproteaseinhibitorsimpairsleishmaniaamazonensissurvivalonmacrophages
AT herbertleoneldematosguedes pretreatmentwithserineproteaseinhibitorsimpairsleishmaniaamazonensissurvivalonmacrophages